SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-030232
Filing Date
2022-05-31
Accepted
2022-05-31 08:10:44
Documents
14
Period of Report
2022-05-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea160797-8k425_biotech.htm   iXBRL 8-K 43359
2 PRESS RELEASE ea160797ex99-1_biotechacq.htm EX-99.1 21644
  Complete submission text file 0001213900-22-030232.txt   305525

Data Files

Seq Description Document Type Size
3 XBRL DEFINITION FILE biotu-20220531_def.xml EX-101.DEF 27485
4 XBRL LABEL FILE biotu-20220531_lab.xml EX-101.LAB 37982
5 XBRL PRESENTATION FILE biotu-20220531_pre.xml EX-101.PRE 26103
6 XBRL SCHEMA FILE biotu-20220531.xsd EX-101.SCH 4129
8 EXTRACTED XBRL INSTANCE DOCUMENT ea160797-8k425_biotech_htm.xml XML 6912
Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Filer) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39935 | Film No.: 22980565
SIC: 2834 Pharmaceutical Preparations